Investor Presentation

August 13, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, M/s Zota Health Care Limited, are submitting herewith enclosed the Investor Presentation. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Zota Health Care Limited INVESTOR PRESENTATION Q1FY27 Safe Harbour This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer documents. This presentation has been prepared on the basis of information and data available with the Company consider reliable. This presentation may not contain all the information that you may consider material. Any liability in respect of the content of or any omission from this presentation is expressly excluded. Stakeholders are advised to compare the data provided in the presentation with the full financial results available on the website of the Company as well as on website of NSE. This presentation contains “forward-looking statements”, including “future oriented financial information” and “financial outlook”. These forward-looking statements are based on management’s current expectations and beliefs and are subject to uncertainty. Actual results may vary from the information contained in this presentation due to changes in government policies, regulations, economics reforms, natural calamities, competition, technology, etc. The company is not under any obligation to provide any update or alter forward looking statements, whether as a result of any new information or future events. AGENDA Company Overview Business Overview Davaindia Domestic Operations Export Operations Financial Overview Company Overview Zota Healthcare At a Glance Financial Highlights (FY26 - Consolidated) Revenue from Operations Zota Health Care Ltd., a Headquartered in Surat and Davaindia, launched in 2017, The strategic business model publicly listed company on employing dedicated is a retail generic pharmacy allows Davaindia to be both ₹ 53,865.75 NSE, has established a professionals, Zota Health chain that provides quality backward and forward lakhs significant footprint in the Care Ltd. has grown notably, generic medicines consisting integrated, ensuring control of Indian healthcare sector since cementing its place in the of 2,000+ SKUs. the entire product life cycle. its inception in 2000. Indian healthcare market. Gross Profit ₹ 32,468.90 Business Verticals lakhs 1,855 COCO Stores* SKU’s in Davaindia Operational Davaindia Davaindia 2,000+ 2,825 portfolio Stores* EBITDA FOFO Stores* ₹ 2,597.73 Domestic 4,000+ Products covering major 1,050+ Distributors currently, WHO Recognized lakhs therapeutic segments present across India manufacturing partners Gross Formulations Product approvals received Exports markets Exports 30+ 250+ 325 manufactured for out of 586 dossiers Merchandise Value served exports applications Davaindia Everyday 87.78% stake in Everyday Herbal Group strengthens Zota ₹ 45,706 Expands the product portfolio in the high-revenue Health Care’s supply chain and product development Herbal Group over-the-counter (OTC) category lakhs capabilities As of 30th June 2026 Our Journey Strengthening Core And Pioneering Davaindia 2017 2018 Setting Up Formulations Export Business Introduced Davaindia, a private sector Achieved ₹10+ Cr in Export Sales; & 75+ generic pharmacy, via three pilot outlets Davaindia stores Foundational Steps In 2020 Domestic Marketing 2010 2011 2019 Opened ~150 Davaindia outlets With over 250 outlets, Davaindia became Inaugurated an export- Commenced exports, the largest and fastest growing private oriented formulations expanding business to sector generic pharmacy chain Migrated to the Main Board of NSE manufacturing unit in African countries 2004 2000 Sachin, SEZ 2022 2021 Acquired all brand names Zota Health Care - Davaindia secured its position as India’s Inception of COCO stores of Sayona Medicare via an Incorporated 2012 2013 largest private sector generic pharmacy with over 500 locations nationwide 2023 Secured WHO-GMP Acquired trademark 2024 approval for the 2007 and brand names of manufacturing unit Total Davaindia stores Redix Lifecare Everyday Herbal Group – 56% stake acquired, at SEZ reaching 600 licensed by Khadi and Village Industrial Acquired Mexon Health Care Limited's trademark Commission, Government of India. and brand, including Health Park Laboratories and 2025 Aaron Biotech divisions 2014 2017 2026 Obtained regulatory • Further acquired 9.98% equity Received regulatory • QIP ₹350 Cr successfully completed. approvals from stake in EHBCPL ( Total stake 2010 approval for SEZ plant • Davaindia Expanded to 2,825 active stores with Kenya (PPB) and Sri stands at 65.98%. from Tanzania (TFDA) COCO 1,855 & FOFO 970 Lanka (CDDA) for • Acquired 100% stake in Curexis. • Incorporation of a wholly owned Zota Pharmaceuticals and Atoz Pharmaceuticals the Sachin SEZ • Further acquired 21.80% stake in EHBC Listed on NSE - SME subsidiary, KMHP Ventures Limited, merged with Zota Health Care plant (Shareholding is 87.78%). for marketing and trading. • Launch of “All day store” through EHBC. 6 • Brand Ambassador appointments- Suniel Shetty, M.S Dhoni. As of 30th June 2026 Management Profile Ketankumar Zota Moxesh Zota Sujit Paul Chairman And Managing Director Group Chief Executive Non-executive Director Officer Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Pharmacy degree • Holds a Bachelor’s degree in pharmacy & • Featured on Times Now and Brand Vision • Won ‘Lifetime Achievement Award’ from DCGI & Master’s degree in international marketing & • Honored among Asia One's Top 100 Global the title of ‘Pharma Ratna Asia’. business management, BPP University in UK leaders • Under his guidance, company has established a • Last stint was with Reliance Retail as Vice global presence in 30+ countries President and also worked with Apollo Pharmacy, StayHappi, Columbia Asia Hospitals, etc. Himanshu Zota Kamlesh Zota Viren Zota Whole Time Director Whole Time Director Whole Time Director Total Experience: 30+ Total Experience: 27+ Total Experience: 15+ • Holds a Diploma in Pharmacy degree and a • Holds a bachelor’s degree in pharmacy • Holds a bachelor’s degree in Business Diploma in Computer Application • Earlier worked with Torrent Pharma, Unique Administration, B.R.C.M. College • Playing a vital role in the planning & Pharmaceuticals Laboratories. • Earlier worked in Franchisee Marketing, where implementation of Davaindia project. he gained hands-on experience across various regions of India. Company Structure Step down subsidiary Supplying products at Davaindia ALP* Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic Export COCO (Sales to FOFO# stores) (COCO# stores) FOFO Sales through COCO Sales through Zota Health Care Davaindia Health Mart Limited Limited # COCO – Company-Owned Company-Operated FOFO – Franchisee-Owned Franchisee-Operated *ALP – Arm's length price Business Overview Business Verticals DAVAINDIA Revenue contribution (Q1FY27) • A Retail generic pharmacy chain providing quality generic medicines. 02 30% – 90% Store variants • Focuses only on private-label products in: Ever [Showing first 8,000 characters — download PDF for full document]